| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 3 | +0.00% | -1.39% | -0.59% | -0.80% | -1.79% | — |
| 14d | 3 | +0.00% | -0.75% | +0.96% | -1.71% | -2.96% | — |
| 30d | 3 | +100.00% | +21.40% | +4.11% | +17.29% | +18.98% | — |
| 60d | 3 | +100.00% | +29.84% | +3.46% | +26.38% | +38.04% | — |
| 90d | 3 | +100.00% | +43.68% | -3.62% | +65.24% | +65.24% | — |
| 180d | 3(1 pending) | +100.00% | +46.21% | +1.00% | +45.22% | +45.22% | — |
| 1y | 3(1 pending) | +100.00% | +24.28% | +17.91% | +6.37% | +6.37% | — |
| 2y | 3(1 pending) | +0.00% | -81.68% | +48.79% | -130.46% | -130.46% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| GENB GENERATE BIOMEDICINES, INC. | SALE | 1,265,822 | — | — | 0 | Mar 2, 2026 | Mar 2, 2026 ↗ | View → |
| GENB GENERATE BIOMEDICINES, INC. | PURCHASE | 12,723,940 | — | — | 12,723,940 | Mar 2, 2026 | Mar 2, 2026 ↗ | View → |
| GENB GENERATE BIOMEDICINES, INC. | PURCHASE | 2,777,752 | — | — | 2,777,752 | Mar 2, 2026 | Mar 2, 2026 ↗ | View → |
| GENB GENERATE BIOMEDICINES, INC. | PURCHASE | 987,491 | — | — | 987,491 | Mar 2, 2026 | Mar 2, 2026 ↗ | View → |
| GENB GENERATE BIOMEDICINES, INC. | PURCHASE | 13,702,224 | — | — | 13,702,224 | Mar 2, 2026 | Mar 2, 2026 ↗ | View → |
| GENB GENERATE BIOMEDICINES, INC. | SALE | 18,483,785 | — | — | 0 | Mar 2, 2026 | Mar 2, 2026 ↗ | View → |
| GENB GENERATE BIOMEDICINES, INC. | PURCHASE | 1,562,500 | $16.00 | $25.00M | 4,340,252 | Mar 2, 2026 | Mar 2, 2026 ↗ | View → |
| GENB GENERATE BIOMEDICINES, INC. | SALE | 2,109,704 | — | — | 0 | Mar 2, 2026 | Mar 2, 2026 ↗ | View → |
| GENB GENERATE BIOMEDICINES, INC. | SALE | 1,500,000 | — | — | 0 | Mar 2, 2026 | Mar 2, 2026 ↗ | View → |
| GENB GENERATE BIOMEDICINES, INC. | SALE | 1,265,822 | — | — | 0 | Mar 2, 2026 | Mar 2, 2026 ↗ | View → |
| GENB GENERATE BIOMEDICINES, INC. | PURCHASE | 1,562,500 | $16.00 | $25.00M | 15,264,724 | Mar 2, 2026 | Mar 2, 2026 ↗ | View → |
| GENB GENERATE BIOMEDICINES, INC. | PURCHASE | 1,562,500 | $16.00 | $25.00M | 1,562,500 | Mar 2, 2026 | Mar 2, 2026 ↗ | View → |
| GENB GENERATE BIOMEDICINES, INC. | SALE | 2,109,704 | — | — | 0 | Mar 2, 2026 | Mar 2, 2026 ↗ | View → |
| GENB GENERATE BIOMEDICINES, INC. | SALE | 843,881 | — | — | 0 | Mar 2, 2026 | Mar 2, 2026 ↗ | View → |
| GENB GENERATE BIOMEDICINES, INC. | SALE | 17,016,215 | — | — | 0 | Mar 2, 2026 | Mar 2, 2026 ↗ | View → |
| GENB GENERATE BIOMEDICINES, INC. | SALE | 2,953,586 | — | — | 0 | Mar 2, 2026 | Mar 2, 2026 ↗ | View → |
| GENB GENERATE BIOMEDICINES, INC. | SALE | 2,531,644 | — | — | 0 | Mar 2, 2026 | Mar 2, 2026 ↗ | View → |
| GENB GENERATE BIOMEDICINES, INC. | PURCHASEGRANT Stock grant | 29,561 | — | — | 29,561 | Feb 26, 2026 | Mar 2, 2026 ↗ | View → |
| MCRB SERES THERAPEUTICS, INC. | PURCHASE | 2,912,748 | $3.15 | $9.18M | 5,875,711 | Jul 5, 2022 | Jul 7, 2022 ↗ | View → |
| MCRB SERES THERAPEUTICS, INC. | PURCHASE | 5,825,495 | $3.15 | $18.35M | 5,825,495 | Jul 5, 2022 | Jul 7, 2022 ↗ | View → |
| MCRB SERES THERAPEUTICS, INC. | SALE | 295,171 | — | — | 2,962,963 | May 17, 2021 | May 19, 2021 ↗ | View → |
| MCRB SERES THERAPEUTICS, INC. | SALE | 1,481,481 | — | — | 2,962,963 | Nov 23, 2020 | Nov 25, 2020 ↗ | View → |
| MCRB SERES THERAPEUTICS, INC. | SALE | 642,180 | — | — | 1,283,282 | Nov 23, 2020 | Nov 25, 2020 ↗ | View → |
| MCRB SERES THERAPEUTICS, INC. | SALE | 43,154 | — | — | 0 | Nov 23, 2020 | Nov 25, 2020 ↗ | View → |
| MCRB SERES THERAPEUTICS, INC. | SALE | 966,234 | — | — | 0 | Nov 23, 2020 | Nov 25, 2020 ↗ | View → |
| MCRB SERES THERAPEUTICS, INC. | SALE | 1,186,310 | — | — | 3,258,134 | Nov 23, 2020 | Nov 25, 2020 ↗ | View → |
| MCRB SERES THERAPEUTICS, INC. | SALE | 3,587,820 | — | — | 4,434,600 | Nov 23, 2020 | Nov 25, 2020 ↗ | View → |